Oramed Pharmaceuticals Inc.

Regulatory Filings • Mar 26, 2024

_________ false

����� ����������� ����	2 381
ORAMED PHARMACEUTICALS INC
Corporation no: 980376008	13866
- - -

	Israel Securities Authority			Tel Aviv Stock Exchange		C003 ( Public )		Reported via MAGNA:	26/03/2024
	www.isa.gov.il			www.tase.co.il				Reference:	2024-02-026131	Time of broadcast: 09:53 09:53

---

Other Report or AnnouncementRegulation 5 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

	The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report on	Form SC13D

ORAMEDPHARMINC_FormSC13D_20240324_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
- - -
Stock Exchange/Market: NASDAQ CM	Date of revision of form structure: 20/02/2024
Address: Avenue of the Americas 01185 , New York 10036   New York , USA Tel: 844-9672633 , 02-5660001 Fax: 02-5660004
E-mail address: office@oramed.com   Company site: www.oramed.com
Previous names of reporting entity:
Name of the Signatory: SILBERMAN DAVID JOSEPH BENJAMIN Position of Signatory in the reporting corporation: CFO & Vice President Finance Name of Employer Company:
Address: Mamilla 20 , Jerusalem 9414904 Telephone: 054-6877398 Facsimile: E-mail: david@oramed.com 1
USA